Skip to main content

Articles

Page 1 of 16

  1. Young men who have sex with men (MSM), are a key population at higher risk of HIV infection yet they are underrepresented in research. We conducted a bio-behavioral survey to estimate HIV prevalence and associ...

    Authors: Samuel Waweru Mwaniki, Peter Mwenda Kaberia, Peter Mwangi Mugo and Thesla Palanee-Phillips
    Citation: AIDS Research and Therapy 2023 20:7
  2. Psychological distress as measured by mental disorders like depression and anxiety is more prevalent in people living with HIV (PLHIV) than in the general population. However, the relationship between mental d...

    Authors: Nolusindiso Ncitakalo, Lovemore Nyasha Sigwadhi, Musawenkosi Mabaso, John Joska and Leickness Simbayi
    Citation: AIDS Research and Therapy 2023 20:6
  3. The COVID-19 epidemic and various control and mitigation measures to combat the widespread outbreak of the disease may affect other parts of health care systems. There is a concern that the COVID-19 pandemic c...

    Authors: SeyedAhmad SeyedAlinaghi, Pegah Mirzapour, Zahra Pashaei, Arian Afzalian, Marcarious M. Tantuoyir, Roghayeh Salmani, Seyed Farzad Maroufi, Parinaz Paranjkhoo, Seyede Parmis Maroufi, Hajar Badri, Sanaz Varshochi, Farzin Vahedi, Esmaeil Mehraeen and Omid Dadras
    Citation: AIDS Research and Therapy 2023 20:4
  4. Treatment management after repeated failure of antiretroviral therapy (ART) is difficult due to resistance and adherence challenges. For people who have failed non-nucleoside reverse transcriptase inhibitor-(N...

    Authors: Robert A. Salata, Beatriz Grinsztejn, Justin Ritz, Ann C. Collier, Evelyn Hogg, Robert Gross, Catherine Godfrey, Nagalingeswaran Kumarasamy, Cecilia Kanyama, John W. Mellors, Carole L. Wallis and Michael D. Hughes
    Citation: AIDS Research and Therapy 2023 20:3
  5. As children living with HIV transition from adolescence into adulthood, they face a considerable burden of psychiatric disorders (PDs) which may vary between the perinatally and behaviorally infected. The know...

    Authors: Anthony A. Olashore, Saeeda Paruk, Oluyemi O. Akanni and Bonginkosi Chiliza
    Citation: AIDS Research and Therapy 2023 20:2
  6. We assessed the virologic efficacy of switching to co-formulated elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate (E/C/F/TDF) in patients with controlled HIV infection.

    Authors: Nathalie De Castro, Alexandre Brun, Pierre Sellier, Gwenn Hamet, Frédéric Mechaï, Valérie Garrait, Amélie Chabrol, Marie-Anne Bouldouyre, Eric Froguel, Didier Troisvallets, Pauline Caraux-Paz, Constance Delaugerre, Willy Rozenbaum and Jean-Michel Molina
    Citation: AIDS Research and Therapy 2023 20:1
  7. Incident syphilis leads to changes in plasma HIV-1 RNA and CD4 + T-cell level in people with HIV (PWH) with viraemia. Its effect in PWH on suppressive antiretroviral therapy (ART) is less clear.

    Authors: Phillip Chan, Tommy H. C. Tang, Ruby T. S. Kwong, Lawrence Chan, Helen S. Y. Chan, K. W. Lam, W. M. Ting, S. K. Yung, Emily C. T. Lam, M. Y. Chu, Wilson Lam, T. C. Wu, Patrick Li and M. P. Lee
    Citation: AIDS Research and Therapy 2022 19:69
  8. Married women have a higher risk of contracting human immunodeficiency virus (HIV) or develop acquired immune deficiency syndrome (AIDS) than men. Knowledge of HIV/AIDS contributes significantly to describing ...

    Authors: Mohammad Nayeem Hasan, Sumi Tambuly, Kaniz Fatema Trisha, Md. Ashiqul Haque, Muhammad Abdul Baker Chowdhury and Md Jamal Uddin
    Citation: AIDS Research and Therapy 2022 19:68
  9. Inflammatory myofibroblastic tumor (IMT) is a rare disease that mostly occurs in younger people and is located in the lungs in the general population. We report a rare case of adrenal IMT in a patient with HIV...

    Authors: Mengmeng Zhang, Hui Liu, Zhiqiang Zhu, Yu Zhang, Yanyan Zhang and Xiaopeng Hu
    Citation: AIDS Research and Therapy 2022 19:66
  10. Substance use among people living with HIV is associated with poor health, social, and psychological outcomes. This study assessed the prevalence of substance use and associated factors among youth attending H...

    Authors: Zahra Morawej, Azan Nyundo, Ally Kinyaga, Veneranda Kirway, Sophia Kagoye, Andrew Turiho and Noeline Nakasujja
    Citation: AIDS Research and Therapy 2022 19:65
  11. Acquired immunodeficiency syndrome (AIDS) is an acquired defect of the cellular immunity associated with the infection by the human immunodeficiency virus (HIV). The disease has reached pandemic proportion and...

    Authors: Henshaw Uchechi Okoroiwu, Ekementeabasi Aniebo Umoh, Edet Effiong Asanga, Uwem Okon Edet, Michael Raymond Atim-Ebim, Edum Abang Tangban, Elizabeth Nkagafel Mbim, Cynthia Amarachi Odoemena, Victor Kanu Uno, Joseph Okon Asuquo, Otu Otu Effiom-Ekaha, Ogechukwu C. Dozie-Nwakile, Ikenna K. Uchendu, Chidiebere Peter Echieh, Kingsley John Emmanuel, Regina Idu Ejemot-Nwadiaro…
    Citation: AIDS Research and Therapy 2022 19:64
  12. Stigma around human immunodeficiency virus (HIV), injection drug use (IDU), and mental health disorders can be co-occurring and have different impacts on the well-being of people living with HIV (PWH) who use ...

    Authors: Ha V. Tran, Teresa R. Filipowicz, Kelsey R. Landrum, Ha T. T. Nong, Thuy T. T. Tran, Brian W. Pence, Vivian F. Go, Giang M. Le, Minh X. Nguyen, Ruth Verhey, Dixon Chibanda, Hien T. Ho and Bradley N. Gaynes
    Citation: AIDS Research and Therapy 2022 19:63
  13. Key and priority populations (with risk behaviours and health inequities) are disproportionately affected by HIV in Uganda. We evaluated the impact of an intensive case management intervention on HIV treatment...

    Authors: David B. Meya, Agnes N. Kiragga, Elizabeth Nalintya, Grace Banturaki, Joan Akullo, Phillip Kalyesubula, Patrick Sessazi, Hillary Bitakalamire, Joseph Kabanda, Julius N. Kalamya, Alice Namale, Moses Bateganya, Joseph Kagaayi, Steve Gutreuter, Michelle R. Adler and Kiren Mitruka
    Citation: AIDS Research and Therapy 2022 19:62
  14. There are more than 7,800 people living with human immunodeficiency virus (HIV) in Victoria, Australia. Crucial in maximising the individual and population level benefits from antiretroviral therapy (ART) is u...

    Authors: Shivani Bhatt, Mellissa Bryant, Helen Lau, Ban-Kiem Tee, Beng Eu, Jessica O’Bryan, Ian Woolley, Jeni Mitchell, Alan Street, Sheranne Dobinson, Nicholas Medland, Judy Lamb, Andrew Mahony, Adrian Tramontana, Lyn-Li Lim, Amanda Wade…
    Citation: AIDS Research and Therapy 2022 19:61
  15. Tuberculosis (TB) continues to be the leading cause of death for people living with HIV/AIDS (PLHIV), and HIV is the strongest known risk factor for progression to active TB disease for persons with latent TB ...

    Authors: Lisa Kawatsu, Noriyo Kaneko, Mayumi Imahashi, Keisuke Kamada and Kazuhiro Uchimura
    Citation: AIDS Research and Therapy 2022 19:60
  16. Adolescent girls and young women (AGYW) at institutions of higher learning are at high risk of HIV, and conventional HIV testing services may not reach them sufficiently. HIV self-testing (HIVST) scalability c...

    Authors: Ivan Segawa, Sabrina Bakeera-Kitaka, Kenneth Ssebambulidde, Timothy R. Muwonge, Lorraine Oriokot, Kevin Ouma Ojiambo and Andrew Mujugira
    Citation: AIDS Research and Therapy 2022 19:59
  17. The development of antiretroviral therapy (ART) has been effective in suppressing HIV replication. However, severe drug toxicities due to the therapy and its failure in targeting the integrated proviral genome...

    Authors: Ruchira Bhowmik and Binay Chaubey
    Citation: AIDS Research and Therapy 2022 19:58
  18. Although Ethiopia is endemic to viral hepatitis and HIV, data that could guide population-specific interventions are limited. In this study, we determined the seroprevalence of hepatitis B virus (HBV) and hepa...

    Authors: Gebrecherkos Teame, Araya Gebreyesus, Ephrem Tsegay, Mulu Gebretsadik and Kelemework Adane
    Citation: AIDS Research and Therapy 2022 19:57
  19. Adherence to antiretroviral treatment (ART) remains the cornerstone of optimal HIV outcomes, including viral suppression (VS), immune recovery, and decreased transmission risk. For many people with HIV (PWH), ...

    Authors: Christin Kilcrease, Hasiya Yusuf, Joan Park, Aaron Powell, Leon James RN, Jacob Oates RN, Brittany Davis LMSW, Ethel D. Weld, Kelly E. Dooley, Renata Arrington-Sanders and Allison L. Agwu
    Citation: AIDS Research and Therapy 2022 19:56
  20. Consistent and complete adherence is considered an essential requirement for patients on antiretroviral therapy (ART). This study aimed to evaluate the impact of ART duration on ART adherence, identify the tre...

    Authors: Kedi Jiao, Meizhen Liao, Guangmei Liu, Yanmei Bi, Xiuhong Zhao, Qian Chen, Jing Ma, Yu Yan, Chunxiao Cheng, Yijun Li, Wenwen Jia, Lina Wang, Yanwen Cao, Zhonghui Zhao, Xuan Yang, Jing Meng…
    Citation: AIDS Research and Therapy 2022 19:55
  21. Dolutegravir (DTG) is an Integrase Strand Transfer Inhibitor (INSTI) indicated in combination with other antiretroviral agents for the treatment of HIV infection. It is available in a number of pharmaceutical ...

    Authors: Alemayehu L. Duga, Sibongile Magongo, Siphesihle Nhlabatsi, Denis O. Ladwar, Linda Härmark and Leàn Rolfes
    Citation: AIDS Research and Therapy 2022 19:54
  22. Viral load (VL) monitoring of pregnant women living with HIV (PWLHIV) and antiretroviral therapy (ART) may contribute to lowering the risk of vertical transmission of HIV. The aims of this study were to assess...

    Authors: Christine Chiedza Chakanyuka Musanhu, Kudakwashe C. Takarinda, Jawaya Shea, Inam Chitsike and Brian Eley
    Citation: AIDS Research and Therapy 2022 19:52
  23. Monitoring of adherence to antiretroviral treatment (ART) is of utmost importance to prevent treatment failure. Several measures to monitor adherence have been applied in low-resource settings and they all hav...

    Authors: Kennedy M. Ngowi, Linda Minja, I. Marion Sumari-de Boer, Rob E. Aarnoutse, Lyidia Masika, Mirjam A. G. Sprangers, Francis M. Pima, Blandina T. Mmbaga, Peter Reiss and Pythia T. Nieuwkerk
    Citation: AIDS Research and Therapy 2022 19:51
  24. Medication adherence is important to the survival of People Living with HIV (PLHIV) globally. Although, HIV viral load is reduced by antiretroviral therapy (ART), the number of people on ART continues to rise ...

    Authors: Collins Adu, Kofi Akohene Mensah, Bright Opoku Ahinkorah, Dorothy Osei, Andrews William Tetteh and Abdul-Aziz Seidu
    Citation: AIDS Research and Therapy 2022 19:50
  25. We aimed to explore the association between PrEP-related stereotypes and perceived disapproval (hereafter PrEP-related stigma), and PrEP use.

    Authors: Oscar Javier Pico-Espinosa, Mark Hull, Paul MacPherson, Daniel Grace, Mark Gaspar, Nathan Lachowsky, Saira Mohammed, James Demers, Marshall Kilduff, Robinson Truong and Darrell H. S. Tan
    Citation: AIDS Research and Therapy 2022 19:49
  26. Authors: Juan Ignacio García, Johanna Meléndez, Rosa Álvarez, Carlos Mejía-Chew, Holden V. Kelley, Sabeen Sidiki, Alejandra Castillo, Claudia Mazariegos, Cesar López-Téllez, Diana Forno, Nancy Ayala, Joan-Miquel Balada-Llasat, Carlos Rodolfo Mejía-Villatoro, Shu-Hua Wang, Jordi B. Torrelles and Janet Ikeda
    Citation: AIDS Research and Therapy 2022 19:48

    The original article was published in AIDS Research and Therapy 2020 17:62

  27. People living with HIV (PLHIV) have higher risk of COVID-19 infection and mortality due to COVID-19. Health professionals should be able to assess PLHIV who are more likely to develop severe COVID-19 and provi...

    Authors: Evy Yunihastuti, Teguh Harjono Karjadi, Alvina Widhani, Haridana Indah Setiawati Mahdi, Salma Sundari, Aljira Fitya Hapsari, Sukamto Koesnoe and Samsuridjal Djauzi
    Citation: AIDS Research and Therapy 2022 19:47
  28. Previous clinical data have shown that raltegravir-based antiretroviral therapy (ART) with fewer drug-drug interactions (DDIs) and adverse events (AEs) is a good regimen in patients with HIV infection who need...

    Authors: Jing Yang, Guo Wei, Fuqiang Gui, Yong Zhao, Tingyu Chen and Juan Tan
    Citation: AIDS Research and Therapy 2022 19:45
  29. Due to improved coverage and scale-up of antiretroviral therapy (ART), patients are increasingly transferring between ART-providing sites. Self-transfers may constitute a high proportion of patients considered...

    Authors: Arnold Ssemwogerere, Javilla Kakooza Kamya, Lillian Nuwasasira, Claire Ahura, Derrick Isaac Isooba, Edith K. Wakida, Celestino Obua and Richard Migisha
    Citation: AIDS Research and Therapy 2022 19:44
  30. Although combined antiretroviral therapy (cART) has decreased the mortality associated with HIV infection, complete immune reconstitution is not achieved despite viral suppression. Alterations of CD8+ T cells and...

    Authors: Federico Perdomo-Celis, David Arcia-Anaya, Juan Carlos Alzate, Paula A. Velilla, Francisco J. Díaz, Maria Paulina Posada, María T. Rugeles and Natalia A. Taborda
    Citation: AIDS Research and Therapy 2022 19:42
  31. The South African public antiretroviral therapy (ART) programme is considered one of the largest and most successful ART programmes worldwide. Hence, a study exploring the patients’ experiences of the public a...

    Authors: Delarise M. Mulqueeny and Myra Taylor
    Citation: AIDS Research and Therapy 2022 19:41
  32. Patients with acquired immunodeficiency syndrome (AIDS) tend to suffer from several central nervous system (CNS) infections due to hypoimmunity. However, CNS aspergillosis (CNSAG) is extremely rare and difficu...

    Authors: Hong-Hong Yang, Xue-Jiao He, Jing-Min Nie, Shao-Shan Guan, Yao-Kai Chen and Min Liu
    Citation: AIDS Research and Therapy 2022 19:40
  33. The chronic illness trajectory and its outcomes are well explained by the concept of illness identity; the extent to which ill individuals have integrated their diagnosed chronic illness into their identity or...

    Authors: Neo Phyllis Sematlane, Lucia Knight, Caroline Masquillier and Edwin Wouters
    Citation: AIDS Research and Therapy 2022 19:39
  34. Data on safety and effectiveness of RPV from the real-world setting as well as comparisons with other NNRTIs such as efavirenz (EFV) remain scarce.

    Authors: Alessandro Cozzi-Lepri, Lars Peters, Annegret Pelchen-Matthews, Bastian Neesgaard, Stephane De Wit, Isik Somuncu Johansen, Simon Edwards, Christoph Stephan, Georgios Adamis, Therese Staub, Alexandra Zagalo, Pere Domingo, Daniel Elbirt, Katharina Kusejko, Johanna Brännström, Dzmitry Paduta…
    Citation: AIDS Research and Therapy 2022 19:38
  35. Polypharmacy in people living with HIV/AIDS (PLWHA) is a rising morbidity that exacts hefty economic burden on health budgets in addition to other adverse clinical outcomes. Despite recent advances, uncertaint...

    Authors: Mohammed Ibn-Mas’ud Danjuma, Safah Khan, Farah Wahbeh, Lina Mohammad Naseralallah, Unwam E. Jumbo and Abdelnaser Elzouki
    Citation: AIDS Research and Therapy 2022 19:37
  36. We describe a case of a 30-year-old MSM recently diagnosed with HIV, immunocompromised with a purplish or brown rash all over the body for 3 to 4 months. The histopathology of the cutaneous lesions and pleural...

    Authors: Sampada Bangar, Rohit Vashisht, Pratiksha Sonar, Kunal Ghule, Leena Rawat, Arati Mane, Abhijit Kadam, Nomita Chandhiok and Seema Sahay
    Citation: AIDS Research and Therapy 2022 19:36
  37. Strategies to support adherence are constrained by the lack of tools to objectively monitor medication intake in low-resource settings. Pharmacologic measures are objective, but pharmacy refill data is more ac...

    Authors: Jacinta N. Nwogu, Samuel O. Ngene, Chinedum P. Babalola, Adeniyi Olagunju, Andrew Owen, Saye H. Khoo, Olayinka A. Kotila, Baiba Berzins, Hideaki Okochi, Regina Tallerico, Monica Gandhi and Babafemi Taiwo
    Citation: AIDS Research and Therapy 2022 19:35
  38. Since the scale-up of routine viral load (VL) testing started in 2016, there is limited evidence on VL suppression rates under programmatic settings and groups at risk of non-suppression. We conducted a study ...

    Authors: Trudy Tholakele Mhlanga, Bart K. M. Jacobs, Tom Decroo, Emma Govere, Hilda Bara, Prosper Chonzi, Ngwarai Sithole, Tsitsi Apollo, Wim Van Damme, Simbarashe Rusakaniko, Lutgarde Lynen and Richard Makurumidze
    Citation: AIDS Research and Therapy 2022 19:34
  39. Multi-types COVID-19 vaccines have shown safety and efficacy against COVID-19 in adults. Although current guidelines encourage people living with HIV (PLWH) to take COVID-19 vaccines, whether their immune resp...

    Authors: Shi Zou, Mengmeng Wu, Fangzhao Ming, Songjie Wu, Wei Guo, Gifty Marley, Zhongyuan Xing, Zhiyue Zhang, Minxia Zeng, Chao Sun, Jianfeng Zhang, Weiming Tang and Ke Liang
    Citation: AIDS Research and Therapy 2022 19:33
  40. This study investigated prevalence trends and identified the associated factors of HIV, syphilis and hepatitis C virus (HCV) among pregnant women in the Guangxi Zhuang Autonomous Region (Guangxi), Southwest Ch...

    Authors: Shanmei Zhong, Yanyun Ou, Fei Zhang, Zhaosen Lin, Rongye Huang, Aidan Nong, Zhenxian Wu, Huayue Liang, Cai Qin, Qiuyu Wei, Yuan Yang, Dee Yu, Xianyan Tang, Li Ye, Deping Liu, Hao Liang…
    Citation: AIDS Research and Therapy 2022 19:31
  41. Understanding the experiences, needs, preferences, and behaviors of people living with HIV (PLHIV) are critical to tailor HIV treatment. However, there is limited empirical evidence in Ethiopia on the views of...

    Authors: Yihalem Abebe Belay, Mezgebu Yitayal, Asmamaw Atnafu and Fitalew Agimass Taye
    Citation: AIDS Research and Therapy 2022 19:30
  42. There is no other better way to safeguard an infant’s health in the first 6 months of life than exclusive breastfeeding (EBF). Breast milk is valuable in all aspects of an infant’s physical and mental growth a...

    Authors: Rose Faustine and Fabiola Vincent Moshi
    Citation: AIDS Research and Therapy 2022 19:29
  43. Pre-exposure prophylaxis (PrEP) represents a proven biomedical strategy to prevent HIV transmissions among men who have sex with men (MSM) in the United States (US). Despite the design and implementation of va...

    Authors: Ying Wang, Jason W. Mitchell, Chen Zhang and Yu Liu
    Citation: AIDS Research and Therapy 2022 19:28
  44. It has been widely noted that lifetime adherence to antiretroviral therapy (ART) is necessary for HIV treatment outcome; however, retention on ART among people living with HIV (PLWH) remains a great challenge ...

    Authors: Philomena J. Strother, Mathuros Tipayamongkholgul, Varakorn Kosaisevee and Nawarat Suwannapong
    Citation: AIDS Research and Therapy 2022 19:27